UBS Group AG - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LIANBIO
ValueSharesWeighting
Q2 2023$228
-96.5%
100
-97.5%
0.00%
Q4 2022$6,599
+230.0%
4,024
+222.7%
0.00%
Q3 2022$2,000
-98.4%
1,247
-96.3%
0.00%
Q1 2022$124,00033,4910.00%
Other shareholders
LIANBIO shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,282,084$4,929,0004.16%
Perceptive Advisors 56,560,211$122,170,0003.83%
SCHF (GPE), LLC 937,500$2,025,0002.99%
VR Adviser, LLC 5,378,341$11,617,0002.29%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$7,159,0000.52%
Affinity Asset Advisors, LLC 450,000$972,0000.41%
Altium Capital Management LP 315,191$681,0000.27%
RA Capital Management 4,622,574$9,985,0000.27%
22NW, LP 141,223$305,0000.16%
Logos Global Management LP 394,486$852,0000.16%
View complete list of LIANBIO shareholders